AC Portal
Document Navigator

Preprocedural Planning for Transcatheter Aortic Valve Replacement

Variant: 1   Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
US echocardiography transesophageal Usually Appropriate O
MRI heart function and morphology without and with IV contrast Usually Appropriate O
MRI heart function and morphology without IV contrast Usually Appropriate O
CT heart function and morphology with IV contrast Usually Appropriate ☢☢☢☢
MRA chest with IV contrast May Be Appropriate O
MRA chest without and with IV contrast May Be Appropriate O
CTA chest with IV contrast May Be Appropriate ☢☢☢
CTA coronary arteries with IV contrast May Be Appropriate ☢☢☢
US echocardiography transthoracic resting Usually Not Appropriate O
Aortography chest Usually Not Appropriate ☢☢☢
MRA coronary arteries without and with IV contrast Usually Not Appropriate O
MRA coronary arteries without IV contrast Usually Not Appropriate O
CT chest with IV contrast Usually Not Appropriate ☢☢☢
CT chest without and with IV contrast Usually Not Appropriate ☢☢☢
CT chest without IV contrast Usually Not Appropriate ☢☢☢

Variant: 2   Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
CTA chest with IV contrast Usually Appropriate ☢☢☢
CTA abdomen and pelvis with IV contrast Usually Appropriate ☢☢☢☢
CTA chest abdomen pelvis with IV contrast Usually Appropriate ☢☢☢☢☢
US intravascular aorta and iliofemoral system May Be Appropriate (Disagreement) O
MRA abdomen and pelvis without and with IV contrast May Be Appropriate O
MRA abdomen and pelvis without IV contrast May Be Appropriate O
MRA chest abdomen pelvis with IV contrast May Be Appropriate O
MRA chest without and with IV contrast May Be Appropriate O
US duplex Doppler chest abdomen pelvis Usually Not Appropriate O
US echocardiography transesophageal Usually Not Appropriate O
US echocardiography transthoracic resting Usually Not Appropriate O
Aortography chest abdomen pelvis Usually Not Appropriate ☢☢☢☢
CT abdomen and pelvis with IV contrast Usually Not Appropriate ☢☢☢
CT abdomen and pelvis without IV contrast Usually Not Appropriate ☢☢☢
CT chest with IV contrast Usually Not Appropriate ☢☢☢
CT chest without and with IV contrast Usually Not Appropriate ☢☢☢
CT chest without IV contrast Usually Not Appropriate ☢☢☢
CT abdomen and pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢
CT chest abdomen pelvis with IV contrast Usually Not Appropriate ☢☢☢☢
CT chest abdomen pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢
CT chest abdomen pelvis without IV contrast Usually Not Appropriate ☢☢☢☢
CT heart function and morphology with IV contrast Usually Not Appropriate ☢☢☢☢

Panel Members
Summary of Literature Review
Introduction/Background
Special Imaging Considerations
Initial Imaging Definition
Discussion of Procedures by Variant
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
A. Aortography Chest
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
B. CT Chest With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
C. CT Chest Without and With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
D. CT Chest Without IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
E. CT Heart Function and Morphology With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
F. CTA Chest With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
G. CTA Coronary Arteries With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
H. MRA Chest With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
I. MRA Chest Without and With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
J. MRA Coronary Arteries Without and With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
K. MRA Coronary Arteries Without IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
L. MRI Heart Function and Morphology Without and With IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
M. MRI Heart Function and Morphology Without IV Contrast
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
N. US Echocardiography Transesophageal
Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial imaging.
O. US Echocardiography Transthoracic Resting
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
A. Aortography Chest, Abdomen, and Pelvis
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
B. CT Abdomen and Pelvis With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
C. CT Abdomen and Pelvis Without and With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
D. CT Abdomen and Pelvis Without IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
E. CT Chest, Abdomen, and Pelvis With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
F. CT Chest, Abdomen, and Pelvis Without and With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
G. CT Chest, Abdomen, and Pelvis Without IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
H. CT Chest With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
I. CT Chest Without and With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
J. CT Chest Without IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
K. CT Heart Function and Morphology With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
L. CTA Abdomen and Pelvis With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
M. CTA Chest, Abdomen, and Pelvis With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
N. CTA Chest With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
O. MRA Abdomen and Pelvis Without and With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
P. MRA Abdomen and Pelvis Without IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
Q. MRA Chest, Abdomen, and Pelvis With IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
R. MRA Chest With and Without IV Contrast
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
S. US Duplex Doppler Chest, Abdomen, and Pelvis
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
T. US Echocardiography Transesophageal
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
U. US Echocardiography Transthoracic Resting
Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular aorta and vascular access. Initial imaging.
V. US Intravascular Aorta and Iliofemoral System
Summary of Recommendations
Supporting Documents

The evidence table, literature search, and appendix for this topic are available at https://acsearch.acr.org/list. The appendix includes the strength of evidence assessment and the final rating round tabulations for each recommendation.

For additional information on the Appropriateness Criteria methodology and other supporting documents, please go to the ACR website at https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria.

Appropriateness Category Names and Definitions

Appropriateness Category Name

Appropriateness Rating

Appropriateness Category Definition

Usually Appropriate

7, 8, or 9

The imaging procedure or treatment is indicated in the specified clinical scenarios at a favorable risk-benefit ratio for patients.

May Be Appropriate

4, 5, or 6

The imaging procedure or treatment may be indicated in the specified clinical scenarios as an alternative to imaging procedures or treatments with a more favorable risk-benefit ratio, or the risk-benefit ratio for patients is equivocal.

May Be Appropriate (Disagreement)

5

The individual ratings are too dispersed from the panel median. The different label provides transparency regarding the panel’s recommendation. “May be appropriate” is the rating category and a rating of 5 is assigned.

Usually Not Appropriate

1, 2, or 3

The imaging procedure or treatment is unlikely to be indicated in the specified clinical scenarios, or the risk-benefit ratio for patients is likely to be unfavorable.

Relative Radiation Level Information
References
1. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790-1798.
2. Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011;57(16):1650-1657.
3. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
4. Meredith Am IT, Walters DL, Dumonteil N, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64(13):1339-1348.
5. Mohr FW, Holzhey D, Mollmann H, et al. The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg. 2014;46(5):808-816.
6. Schymik G, Lefevre T, Bartorelli AL, et al. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv. 2015;8(5):657-669.
7. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
8. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124(4):425-433.
9. Webb J, Gerosa G, Lefevre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 64(21):2235-43, 2014 Dec 02.
10. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32(2):198-204.
11. Ueshima D, Fovino LN, D'Amico G, Brener SJ, Esposito G, Tarantini G. Transcatheter versus surgical aortic valve replacement in low- and intermediate-risk patients: an updated systematic review and meta-analysis. Cardiovasc Interv Ther. 34(3):216-225, 2019 Jul.
12. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2012;6(6):366-380.
13. Barbanti M, Yang TH, Rodes Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244-253.
14. Binder RK, Leipsic J, Wood D, et al. Prediction of optimal deployment projection for transcatheter aortic valve replacement: angiographic 3-dimensional reconstruction of the aortic root versus multidetector computed tomography. Circ Cardiovasc Interv. 2012;5(2):247-252.
15. Binder RK, Webb JG, Willson AB, et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol. 62(5):431-8, 2013 Jul 30.
16. Bloomfield GS, Gillam LD, Hahn RT, et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2012;5(4):441-455.
17. Gurvitch R, Wood DA, Leipsic J, et al. Multislice computed tomography for prediction of optimal angiographic deployment projections during transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(11):1157-1165.
18. Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4(8):851-858.
19. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686-1695.
20. Kurra V, Kapadia SR, Tuzcu EM, et al. Pre-procedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. JACC Cardiovasc Interv. 2010;3(1):105-113.
21. Mack MJ. Access for transcatheter aortic valve replacement: which is the preferred route? JACC Cardiovasc Interv. 2012;5(5):487-488.
22. Mylotte D, Dorfmeister M, Elhmidi Y, et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. JACC Cardiovasc Interv. 2014;7(6):652-661.
23. Okuyama K, Jilaihawi H, Kashif M, et al. Transfemoral access assessment for transcatheter aortic valve replacement: evidence-based application of computed tomography over invasive angiography. Circulation. Cardiovascular imaging. 8(1), 2015 Jan.Circ Cardiovasc Imaging. 8(1), 2015 Jan.
24. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62(17):1552-1562.
25. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59(2):113-118.
26. Blanke P, Weir-McCall JR, Achenbach S, et al. Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): An Expert Consensus Document of the Society of Cardiovascular Computed Tomography. [Review]. Jacc: Cardiovascular Imaging. 12(1):1-24, 2019 01.JACC Cardiovasc Imaging. 12(1):1-24, 2019 01.
27. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57-185.
28. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1-23; quiz 101-102.
29. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(13):e1-142.
30. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42(4):S1-44.
31. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561-632.
32. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e72-e227.
33. American College of Radiology. ACR–NASCI–SIR–SPR Practice Parameter for the Performance and Interpretation of Body Computed Tomography Angiography (CTA). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=164+&releaseId=2.
34. Petronio AS, Angelillis M, De Backer O, et al. Bicuspid aortic valve sizing for transcatheter aortic valve implantation: Development and validation of an algorithm based on multi-slice computed tomography. Journal of cardiovascular computed tomography. 14(5):452-461, 2020 Sep - Oct.
35. Kim WK, Liebetrau C, Fischer-Rasokat U, et al. Challenges of recognizing bicuspid aortic valve in elderly patients undergoing TAVR. Int J Cardiovasc Imaging. 36(2):251-256, 2020 Feb.
36. Yoon SH, Kim WK, Dhoble A, et al. Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2020;76:1018-30.
37. Kim WK, Renker M, Rolf A, et al. Annular versus supra-annular sizing for TAVI in bicuspid aortic valve stenosis. EuroIntervention. 15(3):e231-e238, 2019 Jun 12.
38. Harbaoui B, Montoy M, Charles P, et al. Aorta calcification burden: Towards an integrative predictor of cardiac outcome after transcatheter aortic valve implantation. Atherosclerosis. 246:161-8, 2016 Mar.Atherosclerosis. 246:161-8, 2016 Mar.
39. Murphy DT, Blanke P, Alaamri S, et al. Dynamism of the aortic annulus: Effect of diastolic versus systolic CT annular measurements on device selection in transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 10(1):37-43, 2016 Jan-Feb.
40. Knobloch G, Sweetman S, Bartels C, et al. Inter- and intra-observer repeatability of aortic annulus measurements on screening CT for transcatheter aortic valve replacement (TAVR): Implications for appropriate device sizing. Eur J Radiol. 105:209-215, 2018 Aug.
41. Khalique OK, Hahn RT, Gada H, et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7(8):885-894.
42. Mehier B, Dubourg B, Eltchaninoff H, et al. MDCT planning of trans catheter aortic valve implantation (TAVI): determination of optimal c-arm angulation. Int J Cardiovasc Imaging. 36(8):1551-1557, 2020 Aug.
43. Hansson NC, Norgaard BL, Barbanti M, et al. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. Journal of cardiovascular computed tomography. 9(5):382-92, 2015 Sep-Oct.J Cardiovasc Comput Tomogr. 9(5):382-92, 2015 Sep-Oct.
44. Waldschmidt L, Gossling A, Ludwig S, et al. Impact of left ventricular outflow tract calcification in patients undergoing transfemoral transcatheter aortic valve implantation. EuroIntervention 2021.
45. Francone M, Budde RPJ, Bremerich J, et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting-a consensus document by the European Society of Cardiovascular Radiology (ESCR). European Radiology. 30(5):2627-2650, 2020 May.Eur Radiol. 30(5):2627-2650, 2020 May.
46. Ruile P, Blanke P, Krauss T, et al. Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. Eur Heart J Cardiovasc Imaging. 2016;17(4):458-466.
47. Chaturvedi A, Hobbs SK, Ling FS, Chaturvedi A, Knight P. MRI evaluation prior to Transcatheter Aortic Valve Implantation (TAVI): When to acquire and how to interpret. Insights Imaging 2016;7:245-54.
48. Mayr A, Klug G, Reinstadler SJ, et al. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol. 28(11):4625-4634, 2018 Nov.
49. Pamminger M, Klug G, Kranewitter C, et al. Non-contrast MRI protocol for TAVI guidance: quiescent-interval single-shot angiography in comparison with contrast-enhanced CT. Eur Radiol 2020;30:4847-56.
50. Bernhardt P, Rodewald C, Seeger J, et al. Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol 2016;105:273-8.
51. Wang J, Jagasia DH, Kondapally YR, Herrmann HC, Han Y. Comparison of Non-Contrast Cardiovascular Magnetic Resonance Imaging to Computed Tomography Angiography for Aortic Annular Sizing Before Transcatheter Aortic Valve Replacement. J Invasive Cardiol. 29(7):239-245, 2017 Jul.
52. Woldendorp K, Bannon PG, Grieve SM. Evaluation of aortic stenosis using cardiovascular magnetic resonance: a systematic review & meta-analysis. J Cardiovasc Magn Reson 2020;22:45.
53. Queiros S, Morais P, Dubois C, et al. Validation of a Novel Software Tool for Automatic Aortic Annular Sizing in Three-Dimensional Transesophageal Echocardiographic Images. J Am Soc Echocardiogr. 31(4):515-525.e5, 2018 04.
54. Garcia-Martin A, Lazaro-Rivera C, Fernandez-Golfin C, et al. Accuracy and reproducibility of novel echocardiographic three-dimensional automated software for the assessment of the aortic root in candidates for thanscatheter aortic valve replacement. European heart journal cardiovascular Imaging. 17(7):772-8, 2016 Jul.
55. Rong LQ, Hameed I, Salemi A, et al. Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis. Journal of the American Heart Association. 8(19):e013463, 2019 10.
56. Zahn R, Schiele R, Gerckens U, et al. Transcatheter aortic valve implantation in patients with "porcelain" aorta (from a Multicenter Real World Registry). Am J Cardiol 2013;111:602-8.
57. Kinnel M, Faroux L, Villecourt A, et al. Abdominal aorta tortuosity on computed tomography identifies patients at risk of complications during transfemoral transcatheter aortic valve replacement. Arch Cardiovasc Dis. 113(3):159-167, 2020 Mar.
58. Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2017;69:1313-46.
59. Mach M, Poschner T, Hasan W, et al. The Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement: DataData from the VIenna Cardio Thoracic aOrtic valve registrY (VICTORY). Eur J Clin Invest 2021;51:e13491.
60. Arnett DM, Lee JC, Harms MA, et al. Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures. Catheter Cardiovasc Interv 2018;91:150-56.
61. Gleason TG, Schindler JT, Hagberg RC, et al. Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. Ann Thorac Surg. 105(2):477-483, 2018 Feb.
62. Cannao PM, Muscogiuri G, Schoepf UJ, et al. Technical Feasibility of a Combined Noncontrast Magnetic Resonance Protocol for Preoperative Transcatheter Aortic Valve Replacement Evaluation. J Thorac Imaging 2018;33:60-67.
63. Essa E, Makki N, Bittenbender P, et al. Vascular Assessment for Transcatheter Aortic Valve Replacement: Intravascular Ultrasound Compared With Computed Tomography. J Invasive Cardiol. 28(12):E172-E178, 2016 Dec.
64. American College of Radiology. ACR Appropriateness Criteria® Radiation Dose Assessment Introduction. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Appropriateness-Criteria/ACR-Appropriateness-Criteria-Radiation-Dose-Assessment-Introduction.pdf.
Disclaimer
The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked.  Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document.  The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged.  The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination